Canada’s Top 100 Corporate R&D Spenders 2019
Top Corporate R&D Spenders by Tier - Winners Circle
| Top Corporate R&D Spenders by Tier FY2018 |
R&D Spending
| Rank | Tier 1 | $000 | |
|---|---|---|---|
| 1 | Bombardier Inc. | $1,471,915 | |
| 2 | Magna International Inc. | $761,872 | |
| 3 | Suncor Energy Inc. | $635,000 | |
| Rank | Tier 2 | $000 | |
| 1 | Pfizer Canada Inc. (fs) | $98,247 | |
| 2 | ProMetic Life Sciences Inc. | $94,841 | |
| 3 | Linamar Corporation | $90,664 | |
| Rank | Tier 3 | $000 | |
| 1 | Eli Lilly Canada Inc. (fs) | $29,238 | |
| 2 | Pason Systems Inc. | $26,997 | |
| 3 | Mediagrif Interactive Technologies Inc. | $26,510 | |
R&D Spending Growth (% Change 2017-2018)
| Rank | Tier 1 | % | |
|---|---|---|---|
| 1 | Shopify Inc. | 156.8 | |
| 2 | Stars Group Inc. | 88.8 | |
| 3 | Suncor Energy Inc. | 81.4 | |
| Rank | Tier 2 | % | |
| 1 | Titan Medical Inc. | 154.1 | |
| 2 | Medicago Inc. (fs) | 96.3 | |
| 3 | Clementia Pharmaceuticals Inc. | 59.8 | |
| Rank | Tier 3 | % | |
| 1 | Aptose Biosciences Inc. | 197.9 | |
| 2 | IMV Inc. | 117.6 | |
| 3 | Acasti Pharma Inc. | 101.4 | |
R&D Intensity* (R&D Spending as % of Revenue)
| Rank | Tier 1 | % | |
|---|---|---|---|
| 1 | Shopify Inc. | 32.6 | |
| 2 | BlackBerry Limited | 24.2 | |
| 3 | Sanofi (fs) | 15.2 | |
| Rank | Tier 2 | % | |
| 1 | Medicago Inc. (fs) | 1,254.1 | |
| 2 | Arbutus Biopharma Corporation | 974.5 | |
| 3 | ProMetic Life Sciences Inc. | 200.2 | |
| Rank | Tier 3 | % | |
| 1 | Intellipharmaceutics International Inc. | 631.9 | |
| 2 | POET Technologies Inc. | 261.7 | |
| 3 | Espial Group Inc. | 48.0 | |
Notes:
1. R&D Spending Tiers: Tier 1 = $100 million or more of R&D spending, Tier 2 = $30 million-$99.9 million, Tier 3 = less than $30 million.
*Based on companies with $2 million or more of revenue fs = Foreign subsidiary (included revenue and R&D spending for Canadian operations only)